ClinicalTrials.gov record
Completed Phase 4 Interventional

Prolonging Remission in Depressed Elderly (PRIDE)

ClinicalTrials.gov ID: NCT01028508

Public ClinicalTrials.gov record NCT01028508. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 2:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01028508
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Icahn School of Medicine at Mount Sinai
Other
Enrollment
247 participants

Conditions and interventions

Conditions

Interventions

  • ECT Procedure
  • lithium and Venlafaxine Drug

Procedure · Drug

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2009
Primary completion
Aug 31, 2015
Completion
Feb 29, 2016
Last update posted
Apr 10, 2017

2010 – 2016

United States locations

U.S. sites
10
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Georgia Regents University Augusta Georgia 30912
Mayo Clinic Rochester Minnesota 55905
Hoboken University Medical Center (MSSM satellite site) Hoboken New Jersey 07030
The Zucker Hillside Hospital North Shore-LIJ Health System Glen Oaks New York 11004
Icahn School of Medicine at Mount Sinai New York New York 10029
Columbia University/New York State Psychiatric Institute New York New York 10032
Weill Cornell Medical College White Plains New York 10605
Duke University Durham North Carolina 27710
Wake Forest University Medical Center Winston-Salem North Carolina 27157
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75390

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01028508, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 10, 2017 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01028508 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →